• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对老年新型冠状病毒肺炎感染患者肺纤维化预测的回顾性队列分析

Retrospective cohort analysis on predicting pulmonary fibrosis in elderly SARS-CoV-2-infected patients.

作者信息

Gao Fuguo, Hou Guangdong, Hou Yan, Chen Jian, Wang Yifeng, Zhao Baoyin, Li Yan, Wang Xinxin, Hua Yiying, Jin Faguang, Gao Yongheng

机构信息

Department of Pulmonary and Critical Care Medicine, Tangdu Hospital, The Fourth Military Medical University, Xi'an, China.

Department of Pulmonary and Critical Care Medicine, The 940th Hospital of the Joint Logistics Support Force of People's Liberation Army (PLA), Lanzhou, China.

出版信息

Front Cell Infect Microbiol. 2025 Jun 6;15:1587321. doi: 10.3389/fcimb.2025.1587321. eCollection 2025.

DOI:10.3389/fcimb.2025.1587321
PMID:40546283
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12179164/
Abstract

BACKGROUND

SARS-CoV-2 exhibits rapid transmission with a high susceptibility rate, particularly among the elderly. Pulmonary fibrosis (PF) following SARS-CoV-2 infection is a life-threatening complication. However, predictive models for PF in older patients are lacking.

METHODS

Data from patients with COVID-19 aged 60 and above, collected retrospectively between November 2022 and November 2023 across two independent hospitals, were analyzed. Patients from Tangdu Hospital were divided into training and validation cohorts using a 7:3 allocation ratio, while those from The 940th Hospital of the Joint Logistics Support Force of the People's Liberation Army (PLA) served as the test cohort. Identify the most valuable predictors (MVPs) for PF using Least Absolute Shrinkage and Selection Operator (LASSO) regression, and construct a nomogram based on their regression coefficients derived from logistic regression. The calibration, clinical utility, and discriminatory ability of the nomogram were evaluated using the Hosmer-Lemeshow test, decision curve analysis (DCA), and Receiver Operating Characteristic (ROC) curve, respectively.

RESULTS

Neutrophil percentage, C-reactive protein (CRP), gender, diagnostic classification, and time from symptom onset to hospitalization were identified as the MVPs for PF. The nomogram was developed based on these predictors, In all the three cohorts, the nomogram showed good calibration, clinical utility and discriminatory ability, with Area Under the Curve (AUC) of 0.777, 0.735 and 0.753, respectively. Furthermore, based on the principle of optimizing the balance between sensitivity and specificity, 131.026 was determined as the optimal cutoff value for the nomogram. Accordingly, patients with a nomogram score of 131.026 or higher were classified into the high-risk group.

CONCLUSIONS

This study presents the first nomogram for predicting PF in elderly patients following SARS-CoV-2 infection, which may serve as a clinical tool for risk assessment and early management in this population.

摘要

背景

严重急性呼吸综合征冠状病毒2(SARS-CoV-2)传播迅速,易感性高,在老年人中尤为明显。SARS-CoV-2感染后的肺纤维化(PF)是一种危及生命的并发症。然而,缺乏针对老年患者PF的预测模型。

方法

分析了2022年11月至2023年11月期间在两家独立医院回顾性收集的60岁及以上COVID-19患者的数据。唐都医院的患者按照7:3的分配比例分为训练组和验证组,而来自中国人民解放军联勤保障部队第940医院的患者作为测试组。使用最小绝对收缩和选择算子(LASSO)回归确定PF的最有价值预测因子(MVP),并根据逻辑回归得出的回归系数构建列线图。分别使用Hosmer-Lemeshow检验、决策曲线分析(DCA)和受试者工作特征(ROC)曲线评估列线图的校准、临床实用性和鉴别能力。

结果

中性粒细胞百分比、C反应蛋白(CRP)、性别、诊断分类以及症状出现至住院的时间被确定为PF的MVP。基于这些预测因子构建了列线图。在所有三个队列中,列线图均显示出良好的校准、临床实用性和鉴别能力,曲线下面积(AUC)分别为0.777、0.735和0.753。此外,基于优化敏感性和特异性之间平衡的原则,确定131.026为列线图的最佳截断值。因此,列线图得分131.026及以上的患者被归类为高危组。

结论

本研究提出了首个用于预测SARS-CoV-2感染后老年患者PF的列线图,可作为该人群风险评估和早期管理的临床工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a0f/12179164/21415a75056a/fcimb-15-1587321-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a0f/12179164/097aab49b948/fcimb-15-1587321-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a0f/12179164/4146b16ce412/fcimb-15-1587321-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a0f/12179164/1b69e5e9022e/fcimb-15-1587321-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a0f/12179164/c2de01e37871/fcimb-15-1587321-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a0f/12179164/21415a75056a/fcimb-15-1587321-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a0f/12179164/097aab49b948/fcimb-15-1587321-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a0f/12179164/4146b16ce412/fcimb-15-1587321-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a0f/12179164/1b69e5e9022e/fcimb-15-1587321-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a0f/12179164/c2de01e37871/fcimb-15-1587321-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a0f/12179164/21415a75056a/fcimb-15-1587321-g005.jpg

相似文献

1
Retrospective cohort analysis on predicting pulmonary fibrosis in elderly SARS-CoV-2-infected patients.对老年新型冠状病毒肺炎感染患者肺纤维化预测的回顾性队列分析
Front Cell Infect Microbiol. 2025 Jun 6;15:1587321. doi: 10.3389/fcimb.2025.1587321. eCollection 2025.
2
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
3
A novel nomogram for predicting osteoporosis with low back pain among the patients in Wenshan Zhuang and Miao Autonomous Prefecture of China.中国文山壮族苗族自治州患者中用于预测伴有腰痛的骨质疏松症的新型列线图。
Front Endocrinol (Lausanne). 2025 Jun 5;16:1535163. doi: 10.3389/fendo.2025.1535163. eCollection 2025.
4
The Development and Validation of a Nomogram for Predicting Sepsis Risk in Diabetic Patients with Urinary Tract Infection.预测糖尿病合并尿路感染患者脓毒症风险的列线图的开发与验证
Medicina (Kaunas). 2025 Jan 27;61(2):225. doi: 10.3390/medicina61020225.
5
Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.用于 SARS-CoV-2 感染诊断的快速、即时抗原检测。
Cochrane Database Syst Rev. 2022 Jul 22;7(7):CD013705. doi: 10.1002/14651858.CD013705.pub3.
6
Antibody tests for identification of current and past infection with SARS-CoV-2.抗体检测用于鉴定 SARS-CoV-2 的现症感染和既往感染。
Cochrane Database Syst Rev. 2022 Nov 17;11(11):CD013652. doi: 10.1002/14651858.CD013652.pub2.
7
Exploration of the Therapeutic Efficacy of Azithromycin Sequential Therapy in Children With Mycoplasma Pneumonia.阿奇霉素序贯疗法治疗儿童支原体肺炎的疗效探讨
Br J Hosp Med (Lond). 2025 Jun 25;86(6):1-18. doi: 10.12968/hmed.2025.0005. Epub 2025 Jun 13.
8
A Nomogram for Predicting Pulmonary Complications Following Laparoscopic Surgery in Elderly Patients After the COVID-19 Pandemic.一种用于预测新冠疫情后老年患者腹腔镜手术后肺部并发症的列线图。
Clin Interv Aging. 2025 Jun 13;20:837-848. doi: 10.2147/CIA.S515849. eCollection 2025.
9
Nomogram for prediction of severe postoperative complications in elective hepato-pancreato-biliary surgery after COVID-19 breakthrough infection: A large multicenter study.新冠病毒突破性感染后择期肝胰胆手术严重术后并发症预测列线图:一项大型多中心研究
Hepatobiliary Pancreat Dis Int. 2025 Apr;24(2):147-156. doi: 10.1016/j.hbpd.2024.09.009. Epub 2024 Oct 2.
10
Measures implemented in the school setting to contain the COVID-19 pandemic.学校为控制 COVID-19 疫情而采取的措施。
Cochrane Database Syst Rev. 2022 Jan 17;1(1):CD015029. doi: 10.1002/14651858.CD015029.

本文引用的文献

1
The diverse roles of neutrophils from protection to pathogenesis.中性粒细胞从保护到发病机制的多种作用。
Nat Immunol. 2024 Dec;25(12):2209-2219. doi: 10.1038/s41590-024-02006-5. Epub 2024 Nov 20.
2
Corrigendum to "Practical guidance for the early recognition and follow-up of patients with connective tissue disease-related interstitial lung disease" [Autoimmunity Reviews - Volume 23, Issue 6, June 2024, 103582].《结缔组织病相关间质性肺疾病患者的早期识别与随访实用指南》勘误 [《自身免疫性疾病综述》 - 第23卷,第6期,2024年6月,103582]
Autoimmun Rev. 2024 Oct;23(10):103641. doi: 10.1016/j.autrev.2024.103641. Epub 2024 Oct 5.
3
Profibrotic monocyte-derived alveolar macrophages are expanded in patients with persistent respiratory symptoms and radiographic abnormalities after COVID-19.
COVID-19 后持续存在呼吸道症状和影像学异常的患者中,纤维生成性单核细胞衍生的肺泡巨噬细胞增多。
Nat Immunol. 2024 Nov;25(11):2097-2109. doi: 10.1038/s41590-024-01975-x. Epub 2024 Oct 4.
4
The prognostic role of high-density lipoprotein cholesterol/C-reactive protein ratio in idiopathic pulmonary fibrosis.高密度脂蛋白胆固醇/ C反应蛋白比值在特发性肺纤维化中的预后作用
QJM. 2024 Dec 1;117(12):858-865. doi: 10.1093/qjmed/hcae147.
5
Influenza, SARS-CoV-2, and Their Impact on Chronic Lung Diseases and Fibrosis: Exploring Therapeutic Options.流感、SARS-CoV-2 及其对慢性肺部疾病和纤维化的影响:探索治疗选择。
Am J Pathol. 2024 Oct;194(10):1807-1822. doi: 10.1016/j.ajpath.2024.06.004. Epub 2024 Jul 18.
6
Persistence of SARS-CoV-2 infection and viral intra- and inter-host evolution in COVID-19 hospitalized patients.COVID-19 住院患者中 SARS-CoV-2 感染的持续性及病毒的体内和种间进化。
J Med Virol. 2024 Jun;96(6):e29708. doi: 10.1002/jmv.29708.
7
Post-COVID-19 respiratory sequelae two years after hospitalization: an ambidirectional study.住院两年后新冠病毒感染后呼吸后遗症:一项双向研究
Lancet Reg Health Am. 2024 Apr 17;33:100733. doi: 10.1016/j.lana.2024.100733. eCollection 2024 May.
8
Identifying a survival-associated cell type based on multi-level transcriptome analysis in idiopathic pulmonary fibrosis.基于特发性肺纤维化多层次转录组分析鉴定与生存相关的细胞类型。
Respir Res. 2024 Mar 15;25(1):126. doi: 10.1186/s12931-024-02738-w.
9
Establishment and application of the BRP prognosis model for idiopathic pulmonary fibrosis.特发性肺纤维化 BRP 预后模型的建立与应用。
J Transl Med. 2023 Nov 11;21(1):805. doi: 10.1186/s12967-023-04668-5.
10
Serum C-reactive protein is associated with earlier mortality across different interstitial lung diseases.血清 C 反应蛋白与不同间质性肺疾病患者的早期死亡率相关。
Respirology. 2024 Mar;29(3):228-234. doi: 10.1111/resp.14609. Epub 2023 Oct 1.